The content of this chapter deals with the usefulness and indications of amyloid PET for the diagnosis of patients with Alzheimer’s disease (AD). In addition to a description of amyloid PET itself, topics such as early and differential diagnosis of AD are discussed. Measuring amyloid in CSF as an alternative method to amyloid PET and the associations between cerebral amyloid load and the apolipoprotein E genotype are also covered in this section.
CITATION STYLE
Grimmer, T., & Perryman, J. G. (2018). Imaging of brain amyloid load in early Alzheimer’s disease. In Neuromethods (Vol. 137, pp. 149–156). Humana Press Inc. https://doi.org/10.1007/978-1-4939-7674-4_9
Mendeley helps you to discover research relevant for your work.